167 results Stibbe advises Athora Stibbe is advising insurance and reinsurance group Athora on its acquisition of Vivat N.V. from Anbang and the related sale of Vivat Schadeverzekeringen to NN Group. Stibbe advises KKR Stibbe advises KKR on the acquisition of Exact Software from Apax Partners. Stibbe advises ABN AMRO Stibbe advises ABN AMRO on the sale of a majority stake in Stater to Infosys. Stibbe advises citizenM and its existing shareholders KRC and APG Stibbe advises citizenM hotels and its existing shareholders KRC and APG on an agreement whereby GIC, Singapore’s sovereign wealth fund, will acquire a 25% stake in citizenM valuing the company at €2 billion. 15 aspects of Brexit you did not know A Brexit without a deal, or with a deal that does not cover all relevant aspects, is still a potential scenario. We have highlighted a number of unexpected legal consequences of Brexit in such a no deal or incomplete deal scenario. Stibbe advises TRUMPF Stibbe advises TRUMPF, a leading high-technology company, on the acquisition of the Photonics business from Philips. Stibbe advises Aedifica Stibbe advised Aedifica on the acquisition of a healthcare residence for the elderly in Franeker (Friesland). Stibbe advises Agendia Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management. Stibbe advises Canon Medical Systems Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon. Stibbe advises Heineken Stibbe advises Heineken on its strategic partnership agreement with Sligro Food Group. Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist). Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group. Stibbe advises on the equity offering of ProQR Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR"). Stibbe advises Lundbeck Stibbe advised Lundbeck on the acquisition of Prexton Therapeutics BV for an amount of up to EUR 905 million. Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe. Stibbe advises Aedifica Stibbe's Real Estate Transaction Group advised Aedifica NV, a Belgian listed company investing in healthcare real estate, on the further expansion of its portfolio in the Netherlands. Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations. Stibbe advises SABMiller Advising SABMiller on the EUR 816 million acquisition of Grolsch and its subsequent delisting. Pagination Previous page Page 3 Current page 4 Page 5 Page 6 Next page
Stibbe advises Athora Stibbe is advising insurance and reinsurance group Athora on its acquisition of Vivat N.V. from Anbang and the related sale of Vivat Schadeverzekeringen to NN Group.
Stibbe advises ABN AMRO Stibbe advises ABN AMRO on the sale of a majority stake in Stater to Infosys.
Stibbe advises citizenM and its existing shareholders KRC and APG Stibbe advises citizenM hotels and its existing shareholders KRC and APG on an agreement whereby GIC, Singapore’s sovereign wealth fund, will acquire a 25% stake in citizenM valuing the company at €2 billion.
15 aspects of Brexit you did not know A Brexit without a deal, or with a deal that does not cover all relevant aspects, is still a potential scenario. We have highlighted a number of unexpected legal consequences of Brexit in such a no deal or incomplete deal scenario.
Stibbe advises TRUMPF Stibbe advises TRUMPF, a leading high-technology company, on the acquisition of the Photonics business from Philips.
Stibbe advises Aedifica Stibbe advised Aedifica on the acquisition of a healthcare residence for the elderly in Franeker (Friesland).
Stibbe advises Agendia Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management.
Stibbe advises Canon Medical Systems Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon.
Stibbe advises Heineken Stibbe advises Heineken on its strategic partnership agreement with Sligro Food Group.
Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist).
Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group.
Stibbe advises on the equity offering of ProQR Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR").
Stibbe advises Lundbeck Stibbe advised Lundbeck on the acquisition of Prexton Therapeutics BV for an amount of up to EUR 905 million.
Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.
Stibbe advises Aedifica Stibbe's Real Estate Transaction Group advised Aedifica NV, a Belgian listed company investing in healthcare real estate, on the further expansion of its portfolio in the Netherlands.
Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations.
Stibbe advises SABMiller Advising SABMiller on the EUR 816 million acquisition of Grolsch and its subsequent delisting.